Basal-cell carcinoma
Basal-cell cancer is a very common skin cancer. It is much more common in fair-skinned individuals with a family history of basal-cell cancer and increases in incidence closer to the equator or at higher altitude. There are approximately 800,000 new cases yearly in the United States alone. Up to 30% of Caucasians develop basal-cell carcinomas in their lifetime. In Canada, the most common skin cancer is basal-cell carcinoma (as much as one third of all cancer diagnoses), affecting 1 in 7 individuals over a lifetime.
Microbeam
At the low doses of relevance to environmental radiation exposure, individual cells only rarely experience traversals by an ionizing particle and almost never experience more than one traversal. For example, in the case of domestic radon exposure, cancer risk estimation involves epidemiological studies of uranium miners. These miners inhale radon gas, which then undergoes radioactive decay, emitting an alpha particle This alpha particle traverses the cells of the bronchial epithelium, potentially causing cancer. The average lifetime radon exposure of these miners is high enough that cancer risk estimates are driven by data on individuals whose target bronchial cells are subjected to multiple alpha particle traversals. On the other hand, for an average house occupant, about 1 in 2,500 target bronchial cells will be exposed per year to a single alpha particle, but less than 1 in 10 of these cells will experience traversals by more than one particle. Therefore, in order to extrapolate from miner to environmental exposures, it is necessary to be able to extrapolate from the effects of multiple traversals to the effects of single traversals of a particle.